Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 21,581 shares at $7.62 ($167K) on 2026-01-27, disclosed to the SEC on 2026-01-29.
Seasonal sale ($167k) by President, R&D — this insider has traded RLAY in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.62 | 18,895 | $144K | 86.4% |
| 2 | $8.45 | 2,686 | $23K | 13.6% |
| Total | $7.72 avg | 21,581 | $167K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-08 | $162K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $1.6M | — | Filing → |
| RLAY | SELL | 2026-04-30 | $22K | — | Filing → |